Bumrungrad Hospital PCL
OTC:BUHPY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bumrungrad Hospital PCL
OTC:BUHPY
|
TH |
|
RITES Ltd
NSE:RITES
|
IN |
|
Fenix Resources Ltd
F:4ER
|
AU |
|
T
|
Townsquare Media Inc
F:2T8
|
US |
|
D
|
Diebold Nixdorf Inc
F:DBD
|
US |
|
Zumtobel Group AG
F:T9Z
|
AT |
|
WELL Health Technologies Corp
F:W7V
|
CA |
|
W
|
WPP PLC
SWB:0WP
|
UK |
Wall St Price Targets
BUHPY Price Targets Summary
Bumrungrad Hospital PCL
According to Wall Street analysts, the average 1-year price target for BUHPY is 68.57 USD with a low forecast of 52.9742 USD and a high forecast of 81.1961 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BUHPY's stock price target?
Price Target
68.57
USD
According to Wall Street analysts, the average 1-year price target for BUHPY is 68.57 USD with a low forecast of 52.9742 USD and a high forecast of 81.1961 USD.
What is the Revenue forecast for Bumrungrad Hospital PCL?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Bumrungrad Hospital PCL?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Bumrungrad Hospital PCL?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 3%.
